GUERBET (GBT.PA) Stock Fundamental Analysis
EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR
Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 58 industry peers in the Health Care Equipment & Supplies industry. GBT has an average financial health and profitability rating. GBT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year GBT was profitable.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
In the past 5 years GBT always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.55%, GBT is in line with its industry, outperforming 50.00% of the companies in the same industry.
GBT has a Return On Equity (4.08%) which is in line with its industry peers.
GBT has a Return On Invested Capital of 4.48%. This is comparable to the rest of the industry: GBT outperforms 53.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is below the industry average of 8.02%.
The 3 year average ROIC (4.08%) for GBT is below the current ROIC(4.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROIC | 4.48% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
The Profit Margin of GBT (1.91%) is comparable to the rest of the industry.
GBT's Profit Margin has declined in the last couple of years.
GBT has a Operating Margin of 5.89%. This is comparable to the rest of the industry: GBT outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
GBT's Gross Margin of 77.94% is amongst the best of the industry. GBT outperforms 86.21% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
GBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GBT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
2.2 Solvency
GBT has an Altman-Z score of 2.18. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.18) which is comparable to the rest of the industry.
GBT has a debt to FCF ratio of 16.18. This is a negative value and a sign of low solvency as GBT would need 16.18 years to pay back of all of its debts.
GBT has a Debt to FCF ratio (16.18) which is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.89. This is a neutral value indicating GBT is somewhat dependend on debt financing.
GBT has a worse Debt to Equity ratio (0.89) than 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Altman-Z | 2.18 |
ROIC/WACC0.68
WACC6.58%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT has a Current ratio of 2.32. This is in the better half of the industry: GBT outperforms 67.24% of its industry peers.
A Quick Ratio of 1.13 indicates that GBT should not have too much problems paying its short term obligations.
GBT has a Quick ratio of 1.13. This is comparable to the rest of the industry: GBT outperforms 53.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.20%.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
The Revenue has been growing slightly by 7.05% in the past year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
3.2 Future
Based on estimates for the next years, GBT will show a small growth in Earnings Per Share. The EPS will grow by 7.05% on average per year.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y-1.67%
EPS Next 2Y8.02%
EPS Next 3Y7.05%
EPS Next 5YN/A
Revenue Next Year2.52%
Revenue Next 2Y3.1%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.17, GBT is valued on the expensive side.
Based on the Price/Earnings ratio, GBT is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GBT to the average of the S&P500 Index (27.15), we can say GBT is valued slightly cheaper.
A Price/Forward Earnings ratio of 8.62 indicates a reasonable valuation of GBT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 96.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, GBT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.17 | ||
| Fwd PE | 8.62 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 91.38% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 93.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.37 | ||
| EV/EBITDA | 4.08 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.02%
EPS Next 3Y7.05%
5. Dividend
5.1 Amount
No dividends for GBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GBT (6/30/2025, 5:29:41 PM)
21.8
+0.6 (+2.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap275.55M
Analysts75
Price Target27.8 (27.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP39.2%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-34.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-23.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.17 | ||
| Fwd PE | 8.62 | ||
| P/S | 0.33 | ||
| P/FCF | 11.37 | ||
| P/OCF | 3.39 | ||
| P/B | 0.7 | ||
| P/tB | 0.96 | ||
| EV/EBITDA | 4.08 |
EPS(TTM)1.27
EY5.83%
EPS(NY)2.53
Fwd EY11.61%
FCF(TTM)1.92
FCFY8.79%
OCF(TTM)6.43
OCFY29.48%
SpS66.54
BVpS31.19
TBVpS22.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROCE | 6.33% | ||
| ROIC | 4.48% | ||
| ROICexc | 5.17% | ||
| ROICexgc | 6.14% | ||
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% | ||
| FCFM | 2.88% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.66%
ROICexc(5y)4.72%
ROICexgc(3y)5.5%
ROICexgc(5y)6.1%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.7%
ROICexcg growth 5Y-5.56%
ROICexc growth 3Y2.24%
ROICexc growth 5Y-2.35%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Debt/EBITDA | 2.86 | ||
| Cap/Depr | 77.91% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 2.42 | ||
| Cash Conversion | 66.19% | ||
| Profit Quality | 150.63% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 2.18 |
F-Score5
WACC6.58%
ROIC/WACC0.68
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
EPS Next Y-1.67%
EPS Next 2Y8.02%
EPS Next 3Y7.05%
EPS Next 5YN/A
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
Revenue Next Year2.52%
Revenue Next 2Y3.1%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
EBIT growth 1Y28.18%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year108.81%
EBIT Next 3Y33.55%
EBIT Next 5YN/A
FCF growth 1Y182.76%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y196.03%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%